Non-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology. Guideline uri icon

Overview

abstract

  • This selection from the NCCN Guidelines for Non-Small Cell Lung Cancer (NSCLC) focuses on targeted therapies and immunotherapies for metastatic NSCLC, because therapeutic recommendations are rapidly changing for metastatic disease. For example, new recommendations were added for atezolizumab, ceritinib, osimertinib, and pembrolizumab for the 2017 updates.

authors

publication date

  • April 1, 2017

Research

keywords

  • Carcinoma, Non-Small-Cell Lung
  • Lung Neoplasms

Identity

Scopus Document Identifier

  • 85017563403

Digital Object Identifier (DOI)

  • 10.6004/jnccn.2017.0050

PubMed ID

  • 28404761

Additional Document Info

volume

  • 15

issue

  • 4